Date: March 10. Time: 4:00 PM CET.
Advancing your drug or vaccine candidate from late-stage discovery into the clinic is one of the most critical steps in development. This is the phase when you make key decisions that will have long-term scientific and business impact, frequently under extreme time and cost pressure. For example, developability and manufacturability issues can arise due to post-translational modifications and aggregation, and immunogenicity risks due to the presence of T-cell epitopes.
次のステップへ進む
1
2
3
Explore Suppliers
関連する専門知識を持つ信頼できるパートナーを探す
Review Capabilities
サービス、経験、実績を比較する
Start Your Project
つながり、協業を始める
トピック
.png)
.jpg)
.png)
.avif)
.avif)
